Boost ROI with automation-ready consumables, tailored portfolios, resilient distribution, sustainable packaging, traceable data and strong technical supportDublin, Sept. (GLOBE NEWSWIRE) -- "High ...
This article is sponsored by BellBrook Labs and INTEGRA BIOSCIENCES. High-throughput screening emerged in the late 1980s, driven by advances in chemistry and genomics. With recent breakthroughs in ...
AI, computational design and high-throughput screening are accelerating discovery, while targeted therapies, outsourcing and Asia-Pacific expansion create opportunities.Dublin, Sept. (GLOBE NEWSWIRE) ...
For decades, one of the most powerful ideas in modern pharmacology has been remarkably difficult to pursue systematically: ...
Surface plasmon resonance (SPR) offers researchers a powerful way to observe molecular interactions directly, measuring binding events with exceptional sensitivity and without fluorescent or chemical ...
Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...
At Pharmaron, precision drives everything we do. To ensure consistent, high-quality results, we use the Explorer G3 integrated workstation to fully automate our drug screening workflows for both ...
AI, high-throughput screening, genomics and precision medicine are accelerating drug discovery, while rising disease burdens, R&D investment and emerging-market adoption create opportunities.Dublin, ...
Sygnature Discovery, an integrated drug discovery contract research organization (CRO), reports that it completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory ...
Molecular glue degraders (MGDs) are a powerful approach to target proteins traditionally considered ‘undruggable’. By harnessing the ubiquitin–proteasome system, they can induce protein degradation ...
Drug discovery is the process of identifying, validating, optimizing, and advancing new therapeutic candidates toward clinical development. It includes target discovery, screening, hit identification, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results